News & Updates
Filter by Specialty:

Blue light-filtering intraocular implants do not influence insomnia
For individuals who underwent cataract surgery, the use of blue light-filtering intraocular lenses (BF-IOL) does not appear to reduce the incidence of insomnia, a study reports.
Blue light-filtering intraocular implants do not influence insomnia
11 Feb 2022
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
The risk of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) was substantially reduced among girls who were offered the bivalent human papillomavirus (HPV) vaccine, particularly those who were offered it at age 12–13 years, according to an observational study from England.
Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
10 Feb 2022
Obesity, diabetes, family history up prostate cancer risk in IBD patients
A longitudinal national database study of patients with inflammatory bowel disease (IBD) has identified several risk factors for the development of prostate cancer (PC), including age, obesity, diabetes, married status, family history of PC, and African American race.
Obesity, diabetes, family history up prostate cancer risk in IBD patients
10 Feb 2022
IBD patients anxious over severe COVID-19 risk
Patients with inflammatory bowel disease (IBD) report that the COVID-19 pandemic is a “major concern” for them, reveals a study, noting that the cumulative prevalence is low in this cohort. At-risk patients must be identified and counseled individually.
IBD patients anxious over severe COVID-19 risk
10 Feb 2022
Pfizer/BioNTech shots effective in IBD patients
The Pfizer-BNT162b2 vaccine for the coronavirus disease 2019 (COVID-19) effectively reduces the risk of serious outcomes and hospitalization in patients with inflammatory bowel diseases (IBD), though with slight variance in effectivity with respect to ongoing medications, reports a Qatar study presented at the recently concluded 2022 Crohn’s & Colitis Congress (CCC 2022).